iBet uBet web content aggregator. Adding the entire web to your favor.

The revenue in the 'Cardiology Devices' segment of the medical technology market in Indonesia was forecast to continuously increase between 2024 and 2029 by in total 173.3 million U.S. dollars (+53.46 percent). After the ninth consecutive increasing year, the revenue is estimated to reach 497.44 million U.S. dollars and therefore a new peak in 2029. Notably, the revenue of the 'Cardiology Devices' segment of the medical technology market was continuously increasing over the past years.

Find further information concerning the revenue in the 'Ophthalmic Devices' segment of the medical technology market in Indonesia and the revenue in the 'In Vitro Diagnostics' segment of the medical technology market in Spain.

The Statista Market Insights cover a broad range of additional markets.

Revenue of the cardiology device market in Indonesia from 2020 to 2029 (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

Definition:
The Cardiology Devices market includes diagnostic, monitoring, and surgical devices that are used to treat heart diseases and heart-related problems.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences.
Further information on the key players can be found in the Market Shares boxes.

Citation formats